Cholinergic toxidrome: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
Line 3: | Line 3: | ||
* Organophosphate poisoning |
* Organophosphate poisoning |
||
== Clinical |
== Clinical Manifestations == |
||
* Secretions everywhere |
* Secretions everywhere |
Latest revision as of 16:32, 14 July 2020
Etiology
- Organophosphate poisoning
Clinical Manifestations
- Secretions everywhere
- Bronchorrhea, diarrhea, diaphoresis, emesis, lacrimation, salivation, urination
- Miosis
- Confusion, weakness, seizures
- Muscle fascicultation
- Bradycardia, hypothermia, and tachypnea
Management
- Decontamination if ongoing skin exposure
- ABCs and intensive supportive care including early intubation
- Avoid succinylcholine
- Volume resuscitation without pressors is usually adequate
- Treat with anticholinergics
- Atropine 2 to 5 mg IV, doubled every 3 to 5 minutes until clinically improved
- Titrate to bronchorrhea, not tachycardia or mydriasis
- May need hundreds of milligrams of atropine over several days
- Can add pralidoxime to treat neuromuscular dysfunction
- Atropine 2 to 5 mg IV, doubled every 3 to 5 minutes until clinically improved
- Seizures: treated with benzos